PANAGORA ASSET MANAGEMENT INC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 883677 Boston, MA

Position in PTGX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$714,886

-$11,575,702 QoQ

Shares Held

5,832

-95.0% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#192

of 341 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PANAGORA ASSET MANAGEMENT INC holds $624,607,308 across 78 Biotechnology names. PTGX ranks #54 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	175,291	$109,300,950
2	INCY	Incyte Corp	881,889	$99,970,937
3	XENE	Xenon Pharmaceuticals Inc.	664,031	$40,080,911
4	MIRM	Mirum Pharmaceuticals, Inc.	337,461	$39,506,559
5	TVTX	Travere Therapeutics, Inc.	490,724	$27,878,030
6	JAZZ	Jazz Pharmaceuticals plc	104,935	$25,286,186
7	RLAY	Relay Therapeutics, Inc.	1,291,182	$24,158,015
8	CLDX	Celldex Therapeutics, Inc.	572,538	$21,304,138

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$714,886	5,832	-95.0%	Shares	Sole	2026-08-06
2026-03-31	$12,290,588	116,609	-7.0%	Shares	Sole	2026-05-14
2025-12-31	$10,951,038	125,384	-15.7%	Shares	Sole	2026-02-13
2025-09-30	$9,880,067	148,729	-0.0%	Shares	Sole	2025-11-13
2025-06-30	$8,223,623	148,790	-0.7%	Shares	Sole	2025-08-13
2025-03-31	$7,249,550	149,908	+1974.9%	Shares	Sole	2025-05-15
2021-12-31	$247,095	7,225	-77.0%	Shares	Sole	2022-02-10
2021-09-30	$557,063	31,437	-77.1%	Shares	Sole	2021-11-10
2021-06-30	$6,157,446	137,198	-40.2%	Shares	Sole	2021-08-11
2021-03-31	$5,944,386	229,513	-3.0%	Shares	Sole	2021-05-12
2020-12-31	$4,771,509	236,682	+49.0%	Shares	Sole	2021-02-10
2020-09-30	$3,105,595	158,854	+5.4%	Shares	Sole	2020-11-13
2020-06-30	$2,661,256	150,694	+231.2%	Shares	Sole	2020-08-12
2020-03-31	$321,222	45,499	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.